Cleared Traditional

K893909 - MODIFIED MATERIAL USED IN INFUSION T

K893909 is the FDA 510(k) clearance for MODIFIED MATERIAL USED IN INFUSION T by Quinton, Inc.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K893909 · Quinton, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1989
Decision
87d
Days
Class 2
Risk

K893909 is an FDA 510(k) clearance for the MODIFIED MATERIAL USED IN INFUSION T. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Quinton, Inc. (Seattle, US). The FDA issued a Cleared decision on August 25, 1989 after a review of 87 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Quinton, Inc. devices

Submission Details

510(k) Number K893909 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 1989
Decision Date August 25, 1989
Days to Decision 87 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 129d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 473
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K893909.
MEDI-TRACE ACCU-NATE DEVICE
K891193 · Graphic Controls Corp. · Sep 1989
VOLUMETRIC PUMP SOLUTION SET FOR FLO-GARD 8000
K893716 · Baxter Healthcare Corp · Sep 1989
IMED GEMINI 12 NONVENTED Y-TYPE BLOOD/SOLUTION ADM
K894842 · Imed Corp. · Sep 1989
KENDALL CURITY INTRAVASCULAR CUT DOWN TUBES
K892438 · The Kendal Co. · Jul 1989
KENDALL CURITY EXTENSION TUBES
K892440 · The Kendal Co. · Jul 1989
SURFLO(R) WINGED INFUSION SET
K891063 · Terumo Medical Corp. · Jun 1989